US3711250A - Glucose determination method employing orthotoluidine - Google Patents

Glucose determination method employing orthotoluidine Download PDF

Info

Publication number
US3711250A
US3711250A US00194682A US3711250DA US3711250A US 3711250 A US3711250 A US 3711250A US 00194682 A US00194682 A US 00194682A US 3711250D A US3711250D A US 3711250DA US 3711250 A US3711250 A US 3711250A
Authority
US
United States
Prior art keywords
acid
reagent
color
iron
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00194682A
Other languages
English (en)
Inventor
W Stavropoulos
B Thiegs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of US3711250A publication Critical patent/US3711250A/en
Assigned to FIRST NATIONAL BANK OF CHICAGO THE, CHICAGO, ILLINOIS, A NATIONAL BANKING ASSOCIATION reassignment FIRST NATIONAL BANK OF CHICAGO THE, CHICAGO, ILLINOIS, A NATIONAL BANKING ASSOCIATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SERGEN DIAGNOSTICS, INC.
Assigned to SERAGEN DIAGNOSTIC, INC,., 1200 SOUTH MADISON AVEUE, INDIANAPOLIS, INDIANA 46206, A CORP. OF NEW YORK reassignment SERAGEN DIAGNOSTIC, INC,., 1200 SOUTH MADISON AVEUE, INDIANAPOLIS, INDIANA 46206, A CORP. OF NEW YORK LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: FIRST NATIONAL BANK OF CHICAGO THE
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Definitions

  • An improved ortho-toluidine reagent composition for use in determination of glucose in biological fluids comprises sufiicient oxalic acid or polyphosphoric acid to provide a uniform intensity of color when the composition is reacted with glucose, independently of contamination with trace amounts of iron.
  • ortho-toluidine reagents generally contain from about to about grams per 100 milliliters of ortho-toluidine in glacial acetic acid and often contain a small amount of thiourea usually in a concentration of from about 0.1 to 1 gram per 100 milliliters, to prevent subsequent discoloration of the reagent.
  • the reagents may also contain small amounts of hydrazine to provide uniformity in the formation of color with different lots of reagent composition.
  • the glucose determination is usually performed on a biological fluid such as serum, plasma or urine; however, Whole blood, cerebrospinal fluid, milk, and other biological fiuids may be analyzed.
  • a predetermined volume of sample fluid generally 0.100 milliliter, is mixed with a predetermined volume of ortho-toluidine reagent composition, generally from about 3 to about 5 milliliters, in a suitable container such as a colorimeter cuvette or test tube.
  • the mixture is heated to develop color, typically in a heating block at 100 C.
  • the amount of color produced in the ortho-toluidine color reaction is drastically reduced by the presence of small amounts of iron.
  • Iron may be present in varying amounts as a contaminant in the vials, cuvets, pipets or other glassware used in preparation of the reagent or sample, or it may be introduced as a contaminant in one of the ingredients of the reagent. It may be introduced in varying amounts from water used to wash or rinse labortory glassware. Variations in the degree of iron contamination can bring about undesirable variations in color intensity from lot to lot of reagent composition or from test to test. Both ferric and ferrous iron interfere with the color reaction, and due to the acidic nature of the reagent composition, contact with metallic iron can also result in interference.
  • the interference resulting from iron contamination is manifested by decreased final absorbance. Amounts of iron on the order of l to 2 parts per million have been observed to reduce final absorbance by as much as 30 to 50 percent, so that the analytical results are correspondingly decreased. Such interference, if undetected or uncorrected, can thus pose a significant risk of misdiagnosis based on an erroneously low result.
  • This invention relates to an improvement in orthotoluidine reagent compositions used for determination of the glucose concentration in biological fluids.
  • the invention gives a uniform intensity of color when reacted with a specified quantity of glucose, independently of contamination with small amounts of iron.
  • the intensity of color developed in glucose determinations carried out with a conventional ortho-toluidine reagent composition can be made uniform in the presence of iron in the concentrations ordinarily encountered in iron contamination (e.g., from about zero to about three, up to about ten parts by weight of iron per million parts by weight of reagent composition).
  • Such uniformity can be provided by the addition of a minor amount of oxalic acid, polyphosphoric acid or a mixture thereof to the reagent composition prior to developing color, and preferably prior to mixing the reagent composition with glucose.
  • the addition to the reagent composition of oxalic or polyphosphoric acid in an amount sufiicient to prevent interference by trace amounts of iron provides a reagent composition which gives a consistent uniform absorbance and intensity of color independently of the presence or absence of trace amounts of iron in the ultimate color reaction mixture. Interference is prevented independently of the valence state (ferrous or ferric ion) of the iron contaminant.
  • the reagent composition can be formulated with the same ortho-toluidine and glacial acetic acid and with thiourea and hydrazine and other ingredients (if desired) in the same proportions as reagents typically employed, and the glucose determination can be carried out in the identical procedures, with the same proportions of reagent composition and glucose standard or sample as have been heretofore employed, with the sole modification being the addition to the reagent composition of sufiicient of oxalic acid, polyphosphoric acid or a mixture thereof to provide a substantially uniform final absorbance after maximum color development over a range of iron concentrations of from about zero to about one, to about three to about ten parts of iron per million parts of reagent composition.
  • the oxalic acid brpolyphosphoric acid ingredient can be added to in formulating the reagent, the reagent composition at any time prior to developing color, for example, immediately before adding a sample or a glucose standard solution, or after such addition but prior to heating to develop color.
  • the acid ingredient is preferably added to the other ingredients by parts per million to the maximum expected, generally about 10 parts per million. In general, the final absorbance should appear statistically uniform at the 95 percent confidence level, independently of the presence or absence of iron, the resulting composition will be well protected from interference by iron contamination.
  • the oxalic or polyphosphoric acidingredient is generally employed in amounts of from about 0.01 to about 0.05 to about 0.1 to about 0.5 to about 1 gram of acid per 100 milliliters of reagent composition, to saturation of the composition with the acid. It is generally unnecessary to employ the acid ingredient in amounts greater than about one gram per 100 milliliters, and amounts of from about 0.05 to about 0.5 gram per 100 milliliters of final reagent composition are preferred. It is essential, however, that one of the named acid ingredients be employed.
  • acids such as ethylenedinitrilotetraacetic acid, malonic acid, succinic acid, adipic acid, maleic acid, phthalic acid, citric acid and phosphoric acid are ineifective in preventing the interference caused by iron contamination.
  • the relative proportions of the other ingredients in the reagent composition, and the parameters of the analytical procedure such as proportions of reagent composition and standard or sample, heating time and temperature for color development, wavelength of light at which color intensity is measured, etc. are determined in accordance with known procedures.
  • the ortho-toluidine reagent composition and the glucose determination procedure are conventional in the determination of glucose by reaction with ortho-toluidine as the essential color forming reactant.
  • the reagent compositioribontains from about 5 to about grams of ortho-toluidine per 100 milliliters of ultimate composition and from about 0.1 to about 1 gram of thiourea per 100 milliliters, the remainder of the composition being glacial acetic acid with the required amount of oxalic or polyphosphoric acid and optionally a small amount of hydrazine added to control the'desired final absorbance.
  • a preferred composition contains about 9 grams of ortho-toluidine, 0.5 gram thiourea, 60 to 200 micromoles of hydrazine, and from about 0.01 to 0.5 gram of oxalic or polyphosphoric acid, in glacial acetic acid to obtain a final volume of 100 milliliters.
  • Such reagent composition is preferably employed in glucose determination by mixing one part by volume of a biological fluid sample or a glucosestandard solution with about 30 to 50 parts by volume of reagent composition, heating the mixture in a tube in a heating block or water bath at a temperature of about 100 C.
  • Example 1 A series of ortho-toluidine reagent compositions is prepared by mixing together the following ingredients in the following proportions:
  • Glacial acetic acid q.s. to 100 milliliters.
  • o-Toluidine 1 "grams" 9.0 Thiourea do 0.5 10 Oxalic acid do 0.1 Distilled water milliliter 1.0 Glacial acetic acid, q.s. to 100 milliliters.
  • Each reagent is tested in duplicate with 0.100 milliliters of an aqueous glucose standard solution containing 100 milligrams of glucose per 100 milliliters.
  • Five milliliters of reagent composition are transferred to each of three vials and one vial used as a reagent blank.
  • One hundred microliters of the glucose standard is added to each of the two remaining vials. These two vials are capped and the contents mixed well by shaking for about 5 seconds.
  • the vials are then placed in a heating block at 100 C. for 7 minutes, after which they are then removed and cooled in a cold water bath for 3 minutes.
  • the intensity of the blue-green color given by the glucose standard is then measured at 595 nonometers using a photoelectric colorimeter. (The instrument is previously. adjusted to zero absorbance using the untreated vial of reagent.) The results are set out below.
  • Reagent B (2 p.p.m. Fe++ iron) 17. 3
  • Reagent C (0.1% oxalic acid plus 2 ppm. 32 D Feiron) 5 31. 8 40 Reagent D (0.1% oxalic acid) p 32. 3
  • Example 2 In a similar operation, for reagent compositions E, 50 F, G and H are prepared and tested. The composition of the reagents and the average absorbances obtained are set out below:
  • o-To1uidine 9.0% wJv- Thiourea 0.5% w.[v Polyphosphoric acid 0.1% w.[ 33. 5 2,000 ppm. Fe++ iron solution 0.1% vJv Glacial acetic acid Q.s. to 100% by voi Reagent H:
  • No'rE.-% wJv. represents percentage in weight by volume correspending to grams per 100 millilters; inlv.” represents percentage by volume.
  • Example 3 xalic acid (percent (w./v.)
  • a method for determination of glucose comprising the steps of mixing together predetermined quantities of a color forming reagent and a sample composition comprising glucose and developing color in the mixture resulting from both said mixing steps;
  • the improvement which comprises the step of adding an acid selected from oxalic acid, polyphosphoric acid and mixtures thereof to the color reagent composition prior to the step of developing color, the acid being added in an amount sufficient to provide a uniform intensity of color which is independent of the presence of trace amounts of iron in said mixture.
  • the color reagent composition is prepared by mixing together ortho-toluidine, thiourea, hydrazine and glacial acetic acid in predetermined amounts, and wherein said acid is mixed with the color reagent composition prior to mixing of the reagent composition with the sample.
  • a reagent composition useful for determination of glucose by measuring the intensity of color produced by the reaction of glucose with ortho-toluidine, and comprising a solution of ortho-toluidine in glacial acetic acid comprising a solution of ortho-toluidine in glacial acetic acid; the improvement wherein the reagent composition further comprises from about 0.01 gram per 100 milliliters to about saturation of an acid ingredient selected from oxalic acid, polyphosphoric acid and mixtures thereof, whereby said reagent composition is protected from interference by iron contamination.
  • composition of claim 6 wherein the composition contains from about 0.05 to about 0.5 gram of said acid ingredient per 100 milliliters of ultimate reagent composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
US00194682A 1971-11-01 1971-11-01 Glucose determination method employing orthotoluidine Expired - Lifetime US3711250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19468271A 1971-11-01 1971-11-01

Publications (1)

Publication Number Publication Date
US3711250A true US3711250A (en) 1973-01-16

Family

ID=22718519

Family Applications (1)

Application Number Title Priority Date Filing Date
US00194682A Expired - Lifetime US3711250A (en) 1971-11-01 1971-11-01 Glucose determination method employing orthotoluidine

Country Status (9)

Country Link
US (1) US3711250A (de)
JP (1) JPS4853796A (de)
BE (1) BE790826A (de)
CA (1) CA961746A (de)
DE (1) DE2253482A1 (de)
FR (1) FR2159921A5 (de)
GB (1) GB1400729A (de)
IT (1) IT976407B (de)
NL (1) NL7214723A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280082A1 (fr) * 1974-07-25 1976-02-20 Reveilleau R Procede pour le dosage de la bilirubine
EP0236023A3 (de) * 1986-03-03 1988-09-07 Seymour Norman Blackman Nicht-eindringendes Verfahren zum Messen des Blut-Glucose-Spiegels

Also Published As

Publication number Publication date
CA961746A (en) 1975-01-28
DE2253482A1 (de) 1973-05-03
NL7214723A (de) 1973-05-03
FR2159921A5 (de) 1973-06-22
IT976407B (it) 1974-08-20
GB1400729A (en) 1975-07-23
JPS4853796A (de) 1973-07-28
BE790826A (fr) 1973-04-30

Similar Documents

Publication Publication Date Title
Tetlow et al. An absorptiometric method for determining ammonia in boiler feed-water
Itaya et al. A new micromethod for the colorimetric determination of inorganic phosphate
Kempers Determination of sub-microquantities of ammonium and nitrates in soils with phenol, sodiumnitroprusside and hypochlorite
Speakman et al. Interlaboratory comparison of different analytical techniques for the determination of oxygen-18 abundance
FRIGERIO et al. A simple method for determination of glutaraldehyde
US4308027A (en) Method and composition for direct determination of iron in blood serum
EP0054096B1 (de) Verfahren zum Erzeugen stabilisierter Ureaselösungen
Momose et al. Organic analysis—XXIII: Determination of blood sugar and urine sugar with 3: 6-dinitrophthalic acid
Smith et al. Spectrophotometric determination of silicate in natural waters by formation of α-molybdosilicic acid and reduction with a tin (IV)-ascorbic acid-oxalic acid mixture
Uchida et al. Determination of twelve elements in botanical samples with inductively coupled plasma atomic emission spectrometry after leaching with tetramethylammonium hydroxide and ethylenediaminetetraacetic acid
US3711250A (en) Glucose determination method employing orthotoluidine
US3874853A (en) Process for determining the concentration of inorganic phosphates in human fluids
US20070037289A1 (en) Method of calibrating the zero point of an apparatus used to determine a quantity of silica using a cororimetric method
US3709662A (en) Iron analysis reagent formulation
US4395494A (en) Reagent and method for the determination of hydrazine
KR101942784B1 (ko) 과산화수소 농도의 검출방법 및 검출키트.
US3718433A (en) Method of analyzing of ammonia,urea,and tyrosine
Burcar et al. Spectrophotometric determination of magnesium in blood serum using magon
US3567374A (en) Urea determination
US3732077A (en) Method and composition for determining bun
Treybig et al. Colorimetric determination of total nitrogen in amines with selenium catalyst
Clark et al. Spectrophotometric study of a direct determination of serum calcium
Prokhovnik An extrapolation procedure for the assay of aneurine
CN108088823B (zh) 乳制品中钙含量的检测方法
Sardesai et al. A fluorometric procedure for the determination of ammonia in blood

Legal Events

Date Code Title Description
AS Assignment

Owner name: SERAGEN DIAGNOSTIC, INC,., 1200 SOUTH MADISON AVEU

Free format text: LICENSE;ASSIGNOR:FIRST NATIONAL BANK OF CHICAGO THE;REEL/FRAME:004477/0101

Effective date: 19850913

Owner name: FIRST NATIONAL BANK OF CHICAGO THE, CHICAGO, ILLIN

Free format text: SECURITY INTEREST;ASSIGNOR:SERGEN DIAGNOSTICS, INC.;REEL/FRAME:004477/0081

Effective date: 19850913